Financial

InspireMD Announces Notification Of NYSE AMERICAN Listing Deficiency And Expectation To Regain Compliance

TEL AVIV, ISRAEL–(Marketwired – August 22, 2017) – InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it received a letter from the NYSE […]

Spectranetics Announces Fundamental Change, Make-Whole Adjustment Event, Share Exchange Event and Supplemental Indenture for 2.625% Convertible Senior Notes due 2034

COLORADO SPRINGS, Colo., Aug. 10, 2017 (GLOBE NEWSWIRE) — The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”), a developer and manufacturer of single-use medical devices used in minimally invasive procedures within the cardiovascular system, today announced the occurrence of a Fundamental Change, […]

Philips completes acquisition of The Spectranetics Corporation

Amsterdam, the Netherlands and Colorado Springs, CO, U.S. – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has completed the acquisition of The Spectranetics Corporation (NASDAQ: SPNC), a U.S.-based global leader in vascular intervention and lead management […]

HeartFlow Announces Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on Non-Invasive HeartFlow® FFRct Analysis for Coronary Artery Disease

REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ), Blue Cross Blue Shield of Arizona, Blue Cross of Idaho and Blue Cross Blue Shield of Kansas City have each issued a positive […]

Researchers receive $1.5 million each to study extracellular matrix for cardiovascular research

DALLAS, Aug. 9, 2017 /PRNewswire/ — Two researchers have been awarded grants that could help uncover the next breakthrough in heart-health research, the American Heart Association and The Paul G. Allen Frontiers Group announced Wednesday.  Suneel Apte at the Cleveland Clinic and Jeffrey Holmes at the University […]